Genetic Analysis of Mecp2 Gene in Iranian Patients With Rett Syndrome



Nasiri J¹ ; Salehi M² ; Hosseinzadeh M³ ; Zamani M³ ; Fattahpour S² ; Aryani O⁴ ; Najafabadi EF² ; Jabarzareh M² ; Asadi S² ; Gholamrezapour T² ; Sedghi M² ; Ghorbani F²
Source: Iranian Journal of Child Neurology Published:2019

Abstract

Objectives Rett syndrome is an X linked dominant neurodevelopmental disorder which almost exclusively affects females. The syndrome is usually caused by mutations in MECP2 gene, which is a nuclear protein that selectively binds CpG dinucleotides in the genome. Materials & Methods To provide further insights into the distribution of mutations in MECP2 gene, we investigated 24 females with clinical characters of Rett syndrome referred to Alzahra University Hospital in Isfahan, Iran during 2015-2017. We sequenced the entire MECP2 coding region and splice sites for detection of point mutations in this gene. Freely available programs including JALVIEW, SIFT, and PolyPhen were used to find out the damaging effects of unknown mutations. Results Direct sequencing revealed MECP2 mutations in 13 of the 24 patients. We identified in 13 patients, 10 different mutations in MECP2 gene. Three of these mutations have not been reported elsewhere and are most likely pathogenic. Conclusion Defects in MECP2 gene play an important role in pathogenesis of Rett syndrome. Mutations in MECP2 gene can be found in the majority of Iranian RTT patients. We failed to identify mutations in MECP2 gene in 46% of our patients. For these patients, further molecular analysis might be necessary. © 2019, Iranian Child Neurology Society. All rights reserved.